Some of the stocks that may grab investor focus today are:
- Wall Street expects Winnebago Industries, Inc. WGO to report quarterly earnings at $0.92 per share on revenue of $538.18 million before the opening bell. Winnebago shares fell 0.14 percent to $40.30 in after-hours trading.
- Oracle Corp ORCL reported better-than-expected earnings for its fourth quarter, but issued weak guidance for the first quarter.
- Analysts expect Micron Technology, Inc. MU to post quarterly earnings at $3.11 per share on revenue of $7.72 billion after the closing bell. Micron shares gained 0.22 percent to $59.38 in after-hours trading.
- Anika Therapeutics Inc ANIK shares fell around 21 percent in after-hours trading after reporting top-line results from CINGAL 16-02 clinical trial in knee osteoarthritis study did not achieve statistical significance at primary endpoint. Anika Therapeutics shares fell 20.86 percent to $36.50 in the after-hours trading session.
- Before the opening bell, Actuant Corporation ATU is projected to report quarterly earnings at $0.36 per share on revenue of $306.48 million. Actuant shares gained 0.39 percent to close at $25.95 on Tuesday.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
- La-Z-Boy Incorporated LZB reported upbeat earnings for its fourth quarter, while sales missed estimates. La-Z-Boy shares dropped 6.62 percent to $31.05 in the after-hours trading session.
- Analysts are expecting Schlumberger Limited SLB to have earned $0.46 per share on revenue of $8.30 billion in the latest quarter. Schlumberger will release earnings before the markets open. Schlumberger shares rose 0.21 percent to $65.84 in after-hours trading.
- FedEx Corporation FDX reported stronger-than-expected earnings for its fourth quarter on Tuesday. FedEx shares slipped 0.42 percent to $257.30 in the after-hours trading session.
- After the markets close, Steelcase Inc. SCS is estimated to post quarterly earnings at $0.14 per share on revenue of $754.17 million. Steelcase shares dropped 0.81 percent to close at $15.35 on Tuesday.
- Caladrius Biosciences Inc CLBS shares climbed over 67 percent Tuesday after announcing the company’s CD34+ cell therapy program received FDA regenerative medicine advanced therapy designation for treating refractory angina. Caladrius Biosciences shares jumped 31.62 percent to $8.70 in the after-hours trading session.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in